Benjamin Nicholson
ORCID: 0000-0001-9958-7064Also affiliated with Xilio Therapeutics (United States)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 6 papers. Top paper: “XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer”.
Miso Park, Magali Pederzoli-Ribeil, Uğur Eskiocak, Parker Johnson, Wilson Guzman +14 more
K.G. Suresh Kumar, Michael J. Eddins, Craig A. Leach, David E. Sterner, Michael R. Mattern +2 more
Sooncheol Lee, Ben S. Wittner, Kira Niederhoffer, Benjamin Nicholson, Aditya Bardia +20 more
Julia Philipp, Pavlos Missios, Irun Bhan, Ann Liu, Chittampalli N. Yashaswini +17 more
Yassmin A. Elbanna, Katarzyna Kuryłowicz, Michele Ciboddo, Harrison S. Greenbaum, Nicole S. Arellano +23 more
Jingyun Luan, Xuejie Huang, Daniel Leon, Jennifer Good, Benjamin Nicholson +12 more